BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Ergotamine

A vasoconstrictor found in ergot of Central Europe. It is a serotonin agonist that has been used as an oxytocic agent and in the treatment of MIGRAINE DISORDERS.

299+ PubMed studies analyzed · 15 RCTs · Evidence Score: 42.7

Research Domains

Ergotamine has been studied across 16 research domains including 💊 Pain, 🌤️ Mood & Depression, ❤️ Cardiovascular, 🧠 Focus & Attention, 😴 Sleep. The primary research focus is 💊 Pain with 50% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ergotamine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Lisuride
27 shared targets
Yohimbine
25 shared targets
Pergolide
25 shared targets
Dihydroergotamine
25 shared targets
Oxymetazoline
19 shared targets
Quetiapine
23 shared targets
Bromocriptine
24 shared targets
Methysergide
23 shared targets
Trazodone
18 shared targets
Nortriptyline
26 shared targets
Loading evidence profile...

This evidence profile for Ergotamine is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.